A Buyer's Guide to Healthcare Due Diligence

Quick answer: Healthcare due diligence is standard financial and legal DD plus a sector layer that generalist processes miss: license transferability, clinician credentialing continuity, insurer contract standing, scope-of-license consistency, accreditation currency, and founder dependency. Miss any one of these and the transaction either falls apart late or closes at the wrong price — the money is usually lost in what wasn't examined, not in what was.

In short

• Four workstreams: financial, legal, regulatory, operational-clinical — run with equal depth.
• Healthcare-specific killers: non-transferable licenses, expiring insurer contracts, credentialing gaps, revenue delivered outside licensed scope.
• Verify earnings against insurer remittances, not management accounts alone.
• Diligence findings are negotiation instruments: price adjustments, escrows, earn-outs, or a clean walk-away.

Why generalist DD isn't enough

A standard process verifies the financial statements and the contracts. In a clinic, the asset's actual earning capacity lives elsewhere: in whether the license transfers, whether the doctors stay licensed and stay at all, whether the insurer contracts survive the ownership change, and whether the services generating the revenue sit inside the licensed scope. None of those items appear in a template checklist — and each one can zero out the deal thesis.

The four workstreams

1. Financial

Normalize earnings (owner compensation, personal expenses, one-offs, related-party rent) and then verify them — insurer remittance data and bank statements against reported revenue. Examine receivables aging and denial rates: a clinic can book revenue an insurer will never pay. Concentration analysis by payer, by doctor, by service line.

2. Legal

Corporate structure and ownership chain, the lease (term, assignment rights, landlord consent), employment contracts and end-of-service liabilities, litigation and malpractice history, and the change-of-control clauses buried in every material contract.

3. Regulatory

The healthcare heart of the process. License validity and scope against services actually delivered; the authority's ownership-transfer pathway and timeline; inspection history and open findings; accreditation status and expiry dates against the deal timeline; controlled-substance and radiation (FANR) authorizations where relevant.

4. Operational and clinical

Credentialing files for every clinician — current, complete, matching the roster. Key-person analysis: who generates the revenue and what retains them post-close. Insurer contract standing, tariffs, and transferability. Equipment condition and maintenance records. Patient-base durability: repeat rates, referral sources, and how much of the volume is loyal to the founder personally. See what drives valuation — the same factors, examined from the buyer's side.

Red flags that change the price

• Revenue from services outside the licensed scope
• One insurer contract or one doctor carrying most of the earnings
• Credentialing gaps or clinicians mid-transfer at close
• Insurer contracts that terminate or reprice on change of ownership
• Accreditation expiring inside the transaction window
• Receivables the seller books but the insurers dispute

Findings are instruments, not verdicts

Good diligence rarely ends in a simple yes or no. Findings convert into price adjustments, escrows and holdbacks, retention agreements for key clinicians, earn-outs tied to revenue durability, or conditions precedent on regulatory transfer. The buyers who do well treat the diligence report as the negotiation agenda. And sometimes the finding is the walk-away — the cheapest bad deal is the one you didn't close.

How MedGrowth helps

Transact — Healthcare Investment Advisory coordinates full healthcare-specific due diligence — financial, legal, regulatory, and operational — plus negotiation support and post-acquisition integration so the value priced at close is still there six months later.

Frequently asked questions

How long does healthcare due diligence take? Commonly several weeks to a few months depending on asset complexity and data-room quality — the regulatory transfer pathway often sets the overall deal timeline.

What makes it different from standard business DD? License transferability, credentialing continuity, insurer contract status, and clinical scope risk — healthcare-specific exposures a generalist process typically doesn't surface.

Should the seller know what I'll examine? Sophisticated sellers prepare for exactly this list — see how sellers prepare — which is fine: prepared counterparties close cleaner deals.

Sources

MedGrowth acquisition advisory experience; DHA / DOH / MOHAP transfer and licensing frameworks; FANR; insurer network contract terms. Indicative — scope each process to the asset.